{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:16:16Z","timestamp":1788869776464,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010527","name":"Universit\u00e9 Libre de Bruxelles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010527","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-57666-0","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:51:51Z","timestamp":1781833911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of IgG N-glycan patterns in COVID-19, sepsis and healthy subjects"],"prefix":"10.1038","volume":"16","author":[{"given":"Victoria","family":"Paredes-Orejudo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosra","family":"Helali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axelle","family":"Bourez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Van Antwerpen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim Zouaoui","family":"Boudjeltia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Piagnerelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Marchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Delporte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"57666_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315, 801\u2013810 (2016).","journal-title":"JAMA"},{"key":"57666_CR2","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/cells14120930","volume":"14","author":"JS Saavedra-Torres","year":"2025","unstructured":"Saavedra-Torres, J. S. et al. Inflammasomes and Signaling Pathways: Key Mechanisms in the Pathophysiology of Sepsis. Cells 14, 930 (2025).","journal-title":"Cells"},{"key":"57666_CR3","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1007\/s00134-020-06151-x","volume":"46","author":"C Fleischmann-Struzek","year":"2020","unstructured":"Fleischmann-Struzek, C. et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 46, 1552\u20131562 (2020).","journal-title":"Intensive Care Med."},{"key":"57666_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12871-019-0849-9","volume":"19","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Clinical characteristics, risk factors, immune status and prognosis of secondary infection of sepsis: a retrospective observational study. BMC Anesthesiol. 19, 185 (2019).","journal-title":"BMC Anesthesiol"},{"key":"57666_CR5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/00000658-199204000-00009","volume":"215","author":"P Damas","year":"1992","unstructured":"Damas, P. et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann. Surg. 215, 356\u2013362 (1992).","journal-title":"Ann. Surg."},{"key":"57666_CR6","doi-asserted-by":"publisher","first-page":"36579","DOI":"10.1038\/s41598-025-20299-w","volume":"15","author":"B Wang","year":"2025","unstructured":"Wang, B. et al. Predictive value of PD-1\u2009+\u2009CD3+ T cells for 30-day mortality in patients with sepsis. Sci. Rep. 15, 36579 (2025).","journal-title":"Sci. Rep."},{"key":"57666_CR7","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00134-025-08110-w","volume":"51","author":"G Monneret","year":"2025","unstructured":"Monneret, G. et al. Monocyte HLA-DR expression in septic shock patients: insights from a 20-year real-world cohort of 1023 cases. Intensive Care Med. 51, 1820\u20131832 (2025).","journal-title":"Intensive Care Med."},{"key":"57666_CR8","first-page":"18","volume":"7","author":"D C","year":"2017","unstructured":"C, D. The Role of Inflammatory Biomarkers in Predicting Cardiovascular Events. Eur. J. Cardiovasc. Med. 7, 18\u201321 (2017).","journal-title":"Eur. J. Cardiovasc. Med."},{"key":"57666_CR9","first-page":"70","volume":"12","author":"YY Hu","year":"2025","unstructured":"Hu, Y. Y., Pang, M. M., Wang, H. Y., Li, W. X. & Wang, H. Serum immunoglobulin G predicts mortality and stratifies intravenous immunoglobulin benefit in sepsis patients. Mil Med. Res. 12, 70 (2025).","journal-title":"Mil Med. Res."},{"key":"57666_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13613-021-00952-z","volume":"11","author":"L Alagna","year":"2021","unstructured":"Alagna, L. et al. Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial. Ann. Intensive Care. 11, 161 (2021).","journal-title":"Ann. Intensive Care"},{"key":"57666_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.14712\/23362936.2014.14","volume":"114","author":"M Pr\u016fcha","year":"2013","unstructured":"Pr\u016fcha, M. et al. Presence of hypogammaglobulinemia - a risk factor of mortality in patients with severe sepsis, septic shock, and SIRS. Prague Med. Rep. 114, 246\u2013257 (2013).","journal-title":"Prague Med. Rep."},{"key":"57666_CR12","doi-asserted-by":"publisher","first-page":"1532145","DOI":"10.3389\/fimmu.2025.1532145","volume":"16","author":"H Wang","year":"2025","unstructured":"Wang, H. et al. Immunoglobulin G N-Glycome as a biomarker of mortality risk in Escherichia coli induced sepsis. Front. Immunol. 16, 1532145 (2025).","journal-title":"Front. Immunol."},{"key":"57666_CR13","doi-asserted-by":"publisher","first-page":"P19","DOI":"10.1186\/cc11957","volume":"17","author":"U Kova\u010di\u010d","year":"2013","unstructured":"Kova\u010di\u010d, U., Stari\u010d, F., Kmet, M., Godni\u010d, M. & Kap\u0161, R. Hypogammaglobulinemia in sepsis is not correlated to high circulating angiopoietin-2 levels. Crit. Care. 17, P19 (2013).","journal-title":"Crit. Care"},{"key":"57666_CR14","unstructured":"COVID-19 deaths | WHO COVID-19 dashboard. datadot https:\/\/data.who.int\/dashboards\/covid19\/deaths"},{"key":"57666_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03545.x","volume":"151","author":"A Gonzalez-Quintela","year":"2008","unstructured":"Gonzalez-Quintela, A. et al. Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin. Exp. Immunol. 151, 42\u201350 (2008).","journal-title":"Clin. Exp. Immunol."},{"key":"57666_CR16","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/eji.202149491","volume":"52","author":"MM Vicente","year":"2022","unstructured":"Vicente, M. M. et al. Altered IgG glycosylation at COVID-19 diagnosis predicts disease severity. Eur. J. Immunol. 52, 946\u2013957 (2022).","journal-title":"Eur. J. Immunol."},{"key":"57666_CR17","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1021\/ac900231w","volume":"81","author":"M Thaysen-Andersen","year":"2009","unstructured":"Thaysen-Andersen, M., Mysling, S. & H\u00f8jrup, P. Site-Specific Glycoprofiling of N-Linked Glycopeptides Using MALDI-TOF MS: Strong Correlation between Signal Strength and Glycoform Quantities. Anal. Chem. 81, 3933\u20133943 (2009).","journal-title":"Anal. Chem."},{"key":"57666_CR18","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.jaci.2022.10.035","volume":"151","author":"J Koers","year":"2023","unstructured":"Koers, J. et al. Differences in IgG autoantibody Fab glycosylation across autoimmune diseases. J. Allergy Clin. Immunol. 151, 1646\u20131654 (2023).","journal-title":"J. Allergy Clin. Immunol."},{"key":"57666_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.biologicals.2016.02.003","volume":"44","author":"YD Liu","year":"2016","unstructured":"Liu, Y. D. & Flynn, G. C. Effect of high mannose glycan pairing on IgG antibody clearance. Biologicals 44, 163\u2013169 (2016).","journal-title":"Biologicals"},{"key":"57666_CR20","doi-asserted-by":"publisher","first-page":"125541","DOI":"10.1016\/j.talanta.2023.125541","volume":"270","author":"Y Helali","year":"2024","unstructured":"Helali, Y. et al. Development and validation of online SPE purification coupled to HILIC-fluorescence-MS analysis for the characterization of N-glycans. Talanta 270, 125541 (2024).","journal-title":"Talanta"},{"key":"57666_CR21","doi-asserted-by":"publisher","first-page":"15222","DOI":"10.18632\/aging.103884","volume":"12","author":"J \u0160tambuk","year":"2020","unstructured":"\u0160tambuk, J. et al. Global variability of the human IgG glycome. Aging 12, 15222\u201315259 (2020).","journal-title":"Aging"},{"key":"57666_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/gerona\/glt190","volume":"69","author":"J Kri\u0161ti\u0107","year":"2014","unstructured":"Kri\u0161ti\u0107, J. et al. Glycans Are a Novel Biomarker of Chronological and Biological Ages. J. Gerontol. Biol. Sci. Med. Sci. 69, 779\u2013789 (2014).","journal-title":"J. Gerontol. Biol. Sci. Med. Sci."},{"key":"57666_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad, M. & Martin, J. C. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat. Rev. Immunol. 20, 355\u2013362 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"57666_CR24","doi-asserted-by":"publisher","first-page":"103957","DOI":"10.1016\/j.ebiom.2022.103957","volume":"78","author":"T Pongracz","year":"2022","unstructured":"Pongracz, T. et al. Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19. EBioMedicine 78, 103957 (2022).","journal-title":"EBioMedicine"},{"key":"57666_CR25","doi-asserted-by":"publisher","first-page":"104101","DOI":"10.1016\/j.ebiom.2022.104101","volume":"81","author":"T Petrovi\u0107","year":"2022","unstructured":"Petrovi\u0107, T. et al. IgG N-glycome changes during the course of severe COVID-19: An observational study. EBioMedicine 81, 104101 (2022).","journal-title":"EBioMedicine"},{"key":"57666_CR26","doi-asserted-by":"publisher","first-page":"111799","DOI":"10.1016\/j.celrep.2022.111799","volume":"41","author":"MK Ash","year":"2022","unstructured":"Ash, M. K. et al. Bulk IgG glycosylation predicts COVID-19 severity and vaccine antibody response. Cell. Rep. 41, 111799 (2022).","journal-title":"Cell. Rep."},{"key":"57666_CR27","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.gim.2022.04.005","volume":"24","author":"H Vietzen","year":"2022","unstructured":"Vietzen, H., Danklmaier, V., Zoufaly, A. & Puchhammer-St\u00f6ckl, E. High-affinity Fc\u03b3RIIIa genetic variants and potent NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) responses contributing to severe COVID-19. Genet. Med. 24, 1449\u20131458 (2022).","journal-title":"Genet. Med."},{"key":"57666_CR28","doi-asserted-by":"publisher","unstructured":"de Haan, N. et al. Differences in IgG Fc Glycosylation Are Associated with Outcome of Pediatric Meningococcal Sepsis. mBio 9 https:\/\/doi.org\/10.1128\/mbio.00546-18 (2018).","DOI":"10.1128\/mbio.00546-18"},{"key":"57666_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/glycob\/cww108","volume":"27","author":"MM Lee-Sundlov","year":"2017","unstructured":"Lee-Sundlov, M. M. et al. Circulating blood and platelets supply glycosyltransferases that enable extrinsic extracellular glycosylation. Glycobiology 27, 188\u2013198 (2017).","journal-title":"Glycobiology"},{"key":"57666_CR30","doi-asserted-by":"publisher","first-page":"107671","DOI":"10.1016\/j.jbc.2024.107671","volume":"300","author":"MA Aljohani","year":"2024","unstructured":"Aljohani, M. A., Sasaki, H. & Sun, X. L. Cellular translocation and secretion of sialidases. J. Biol. Chem. 300, 107671 (2024).","journal-title":"J. Biol. Chem."},{"key":"57666_CR31","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1097\/CCM.0b013e31819cebbe","volume":"37","author":"M Piagnerelli","year":"2009","unstructured":"Piagnerelli, M. et al. Neuraminidase alters red blood cells in sepsis. Crit. Care Med. 37, 1244\u20131250 (2009).","journal-title":"Crit. Care Med."},{"key":"57666_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41420-024-02180-3","volume":"10","author":"W Zhu","year":"2024","unstructured":"Zhu, W., Zhou, Y., Guo, L. & Feng, S. Biological function of sialic acid and sialylation in human health and disease. Cell. Death Discov. 10, 415 (2024).","journal-title":"Cell. Death Discov"},{"key":"57666_CR33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/imr.13407","volume":"328","author":"J Kri\u0161ti\u0107","year":"2024","unstructured":"Kri\u0161ti\u0107, J. & Lauc, G. The importance of IgG glycosylation\u2014What did we learn after analyzing over 100,000 individuals. Immunol. Rev. 328, 143\u2013170 (2024).","journal-title":"Immunol. Rev."},{"key":"57666_CR34","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.tibtech.2020.05.009","volume":"38","author":"R Mastrangeli","year":"2020","unstructured":"Mastrangeli, R., Audino, M. C., Palinsky, W., Broly, H. & Bierau, H. The Formidable Challenge of Controlling High Mannose-Type N-Glycans in Therapeutic mAbs. Trends Biotechnol. 38, 1154\u20131168 (2020).","journal-title":"Trends Biotechnol."},{"key":"57666_CR35","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1046\/j.1432-1327.2001.02237.x","volume":"268","author":"O Cordero","year":"2001","unstructured":"Cordero, O. et al. Cell surface human \u03b1L-fucosidase. Eur. J. Biochem. FEBS. 268, 3321\u20133331 (2001).","journal-title":"Eur. J. Biochem. FEBS"},{"key":"57666_CR36","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3390\/cells14171355","volume":"14","author":"H B\u00e4umges","year":"2025","unstructured":"B\u00e4umges, H. et al. Deciphering \u03b1-L-Fucosidase Activity Contribution in Human and Mouse: Tissue \u03b1-L-Fucosidase FUCA1 Meets Plasma \u03b1-L-Fucosidase FUCA2. Cells 14, 1355 (2025).","journal-title":"Cells"},{"key":"57666_CR37","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.7150\/jca.75840","volume":"13","author":"J Fu","year":"2022","unstructured":"Fu, J., Guo, Q., Feng, Y., Cheng, P. & Wu, A. Dual role of fucosidase in cancers and its clinical potential. J. Cancer. 13, 3121\u20133132 (2022).","journal-title":"J. Cancer"},{"key":"57666_CR38","doi-asserted-by":"publisher","first-page":"eabc8378","DOI":"10.1126\/science.abc8378","volume":"371","author":"MD Larsen","year":"2021","unstructured":"Larsen, M. D. et al. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity. Science 371, eabc8378 (2021).","journal-title":"Science"},{"key":"57666_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41590-020-00828-7","volume":"22","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty, S. et al. Proinflammatory IgG Fc structures in patients with severe COVID-19. Nat. Immunol. 22, 67\u201373 (2021).","journal-title":"Nat. Immunol."},{"key":"57666_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0304-4165(99)00166-X","volume":"1473","author":"E Miyoshi","year":"1999","unstructured":"Miyoshi, E. et al. The \u03b11-6-fucosyltransferase gene and its biological significance. Biochim. Biophys. Acta BBA - Gen. Subj. 1473, 9\u201320 (1999).","journal-title":"Biochim. Biophys. Acta BBA - Gen. Subj."},{"key":"57666_CR41","doi-asserted-by":"publisher","unstructured":"Felixberger, P. T. et al. CD21low B cells reveal a unique glycosylation pattern with hypersialylation and hyperfucosylation. Front. Immunol. 16, 1512279. https:\/\/doi.org\/10.3389\/fimmu.2025.1512279 (2025).","DOI":"10.3389\/fimmu.2025.1512279"},{"key":"57666_CR42","doi-asserted-by":"publisher","first-page":"6478","DOI":"10.3390\/ijms25126478","volume":"25","author":"KO Yaykasli","year":"2024","unstructured":"Yaykasli, K. O. et al. Neutrophil Depletion Changes the N-Glycosylation Pattern of IgG in Experimental Murine Sepsis. Int. J. Mol. Sci. 25, 6478 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"57666_CR43","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/bit.21598","volume":"99","author":"Q Zhou","year":"2008","unstructured":"Zhou, Q. et al. Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function. Biotechnol. Bioeng. 99, 652\u2013665 (2008).","journal-title":"Biotechnol. Bioeng."},{"key":"57666_CR44","doi-asserted-by":"publisher","unstructured":"Petrovi\u0107, T. et al. Composition of the immunoglobulin G glycome associates with the severity of COVID-19. Glycobiology cwaa102 https:\/\/doi.org\/10.1093\/glycob\/cwaa102 (2020).","DOI":"10.1093\/glycob\/cwaa102"},{"key":"57666_CR45","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1084\/jem.167.5.1731","volume":"167","author":"R Parekh","year":"1988","unstructured":"Parekh, R., Roitt, I., Isenberg, D., Dwek, R. & Rademacher, T. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J. Exp. Med. 167, 1731\u20131736 (1988).","journal-title":"J. Exp. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57666-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57666-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57666-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:02:27Z","timestamp":1788868947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57666-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57666"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57666-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28026"}}